Send me a link:

*Text messaging rates may apply.

 Dow Down0.19% Nasdaq Up0.45%

More On RANBAXY.BO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Ranbaxy Laboratories Ltd. (RANBAXY.BO)

-BSE
582.35 Down 4.15(0.71%) 12:39AM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 24,668,000   28,940,000   28,016,000   26,835,000  
Cost of Revenue9,249,000  10,459,000  10,275,000  9,321,000  
Gross Profit 15,419,000   18,481,000   17,742,000   17,513,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses24,114,000  27,253,000  26,927,000  24,973,000  
Operating Income or Loss 555,000   1,687,000   1,089,000   1,861,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes555,000  1,687,000  1,089,000  1,861,000  
Interest Expense(689,000)(543,000)(503,000)(488,000)
Income Before Tax -   -   -   -  
Income Tax Expense1,099,000  981,000  570,000  311,000  
Minority Interest57,000  33,000  (16,000)(11,000)
Net Income From Continuing Ops(793,000)(1,622,000)(4,525,000)(5,231,000)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (737,000) (1,589,000) (4,542,000) (5,242,000)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in INR.